Clinical Trial Update: Ultrasound and Withdrawal of Biological DMARDs in Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on ultrasound assessment and withdrawal of biological DMARDs in rheumatoid arthritis; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: Medical University of Graz | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED